Do you have recurrent platinum sensitive ovarian cancer?
May 2012
Please note that the interviewers have sufficient people to talk to for the first round of interviews but they will be looking to conduct a second round in the autumn and if you are interested in being involved please conatct Rachle Lewington direct - email address below
Ovacome have been asked by a market research company who are carrying out a series of interviews as part of the development of a new treatment. They would like to talk to women affected by recurrent platinum sensitive ovarian cancer (PSOC) ie cancer that has recurred but still responds to a platinum drug - about how the condition effects your life and about the side effects of the treatments you take.
They would like to talk to you on the phone or in person (whichever you are most comfortable with) for up to an hour. You would receive a small honorarium for your time and the information that you give will be helpful in the development of this treatment. All interviews will be carried out by Rachel Lewington, a director at LDA Research. We will not pass your details on to any third parties and will treat the information that you give with respect and with strict confidentiality. We follow MRS and BHBIA codes of conduct.
If you would like some further information please contact Rachel at: rachel.lewington@ldaresearch.co.uk. Many thanks.